4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-26-000175
Director sold 318 shares at $423.73 ($134,746)
- Director acquired 943 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Bhatia Sangeeta N. · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-05-01 | Grant or award : show line 1 in the form 10b5-1 | +943 | 5,242 | D | ||
| 2026-05-04 | Sale : show line 2 in the form 10b5-1 | −318 | $423.73 | $134,746 | 4,924 | D |
| Open-market sales · 318 sh · avg $423.73 · $134,746 | ||||||
Loading xslF345X06/wk-form4_1778014276.xml…